South Korea Ophthalmic Photocoagulator Market Size & Outlook

The ophthalmic photocoagulator market in South Korea is expected to reach a projected revenue of US$ 4.1 million by 2028. A compound annual growth rate of 6.7% is expected of South Korea ophthalmic photocoagulator market from 2022 to 2028.
Revenue, 2021 (US$M)
$2.6
Forecast, 2028 (US$M)
$4.1
CAGR, 2022 - 2028
6.7%
Report Coverage
South Korea

South Korea ophthalmic photocoagulator market highlights

  • The South Korea ophthalmic photocoagulator market generated a revenue of USD 2.6 million in 2021 and is expected to reach USD 4.1 million by 2028.
  • The South Korea market is expected to grow at a CAGR of 6.7% from 2022 to 2028.
  • In terms of segment, diabetic retinopathy was the largest revenue generating application in 2021.
  • Diabetic Retinopathy is the most lucrative application segment registering the fastest growth during the forecast period.


Ophthalmic photocoagulator market data book summary

Market revenue in 2021USD 2.6 million
Market revenue in 2028USD 4.1 million
Growth rate6.7% (CAGR from 2021 to 2028)
Largest segmentDiabetic retinopathy
Fastest growing segmentDiabetic Retinopathy
Historical data2016 - 2020
Base year2021
Forecast period2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationGlaucoma, Diabetic Retinopathy, Age Related Macular Degeneration, Macular Edema
Key market players worldwideLumenis, IRIDEX Corp, Alcon Inc, Quantel Medical, Nidek Medical, Johnson & Johnson, Topcon Corp, Bausch & Lomb Corp, Meridian Bioscience


Other key industry trends

  • In terms of revenue, South Korea accounted for 1.7% of the global ophthalmic photocoagulator market in 2021.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Asia Pacific, China ophthalmic photocoagulator market is projected to lead the regional market in terms of revenue in 2028.
  • India is the fastest growing regional market in Asia Pacific and is projected to reach USD 6.5 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Ophthalmic Photocoagulator Market Companies

Name Profile # Employees HQ Website

South Korea ophthalmic photocoagulator market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ophthalmic photocoagulator market will help companies and investors design strategic landscapes.


Diabetic retinopathy was the largest segment with a revenue share of 26.92% in 2021. Horizon Databook has segmented the South Korea ophthalmic photocoagulator market based on glaucoma, diabetic retinopathy, age related macular degeneration, macular edema covering the revenue growth of each sub-segment from 2016 to 2028.


Reasons to subscribe to South Korea ophthalmic photocoagulator market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of South Korea ophthalmic photocoagulator market databook

  • Our clientele includes a mix of ophthalmic photocoagulator market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the South Korea ophthalmic photocoagulator market , including forecasts for subscribers. This country databook contains high-level insights into South Korea ophthalmic photocoagulator market from 2016 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

South Korea ophthalmic photocoagulator market size, by application, 2016-2028 (US$M)

South Korea Ophthalmic Photocoagulator Market Outlook Share, 2021 & 2028 (US$M)

South Korea ophthalmic photocoagulator market size, by application, 2016-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more